摘要:
A transceiver system for interfacing digital modems with radio frequency signals including an antenna, an antenna interface system and a modem interface system separated by a cable. The antenna is placed in a location having optimal reception and in close proximity to the antenna interface system. The cable couples the antenna interface system to the modem interface system. The modem interface system includes a two state variable attenuator and an attenuation register that are configured to either reduce the strength of the receive (Rx) signal when the modems are located near a base station, or to transmit the Rx signal without attenuation when the concentrated subscriber unit is at a more distant location. The outgoing, or transmit (Tx), signal is also attenuated in a similar manner to the incoming signal. A signal loss detection system includes a detector located in the modem interface system that receives an oscillating signal transmitted from the antenna interface system through the coaxial cable. A differentiating integrator then determines the amount of signal loss experienced by this oscillating signal during transmission through the coaxial cable and attenuates the signal from the antenna interface system accordingly so the amount of loss experienced remains constant. DC power is transmitted from the modem interface system to the antenna interface system through the coaxial cable. A maximum power limiting system detects when the signal being generated exceeds the capacity of the transmit power amplifier and transmits an alarm signal to the modem interface system.
摘要:
This invention is directed towards a method of using visible light at wavelengths of at least 500 nm and above in combination with a sensitizer having a flavin moiety to reduce any pathogens that may be contained in blood and blood components. By exposing the blood and blood components to light of 500 nm and higher, only the sensitizer that is bound to nucleic acids of the pathogens will be activated, thus destroying the sensitizer-pathogenic nucleic acid complex. Because unbound sensitizer is not activated at this wavelength, damage to blood and blood components caused by photolysis of unbound sensitizer may be avoided.